Filter News
Area of Research
News Type
News Topics
- (-) Biomedical (2)
- (-) Frontier (2)
- (-) Space Exploration (2)
- 3-D Printing/Advanced Manufacturing (1)
- Advanced Reactors (1)
- Artificial Intelligence (6)
- Big Data (4)
- Bioenergy (2)
- Computer Science (23)
- Cybersecurity (2)
- Energy Storage (1)
- Environment (2)
- Exascale Computing (2)
- Grid (1)
- Materials Science (1)
- Nanotechnology (1)
- Neutron Science (1)
- Nuclear Energy (2)
- Physics (1)
- Quantum Science (4)
- Security (1)
- Summit (9)
- Sustainable Energy (2)
- Transportation (1)
Media Contacts
Gina Tourassi has been appointed as director of the National Center for Computational Sciences, a division of the Computing and Computational Sciences Directorate at Oak Ridge National Laboratory.
The type of vehicle that will carry people to the Red Planet is shaping up to be “like a two-story house you’re trying to land on another planet.
Using the Titan supercomputer at Oak Ridge National Laboratory, a team of astrophysicists created a set of galactic wind simulations of the highest resolution ever performed. The simulations will allow researchers to gather and interpret more accurate, detailed data that elucidates how galactic winds affect the formation and evolution of galaxies.
OAK RIDGE, Tenn., May 7, 2019—The U.S. Department of Energy today announced a contract with Cray Inc. to build the Frontier supercomputer at Oak Ridge National Laboratory, which is anticipated to debut in 2021 as the world’s most powerful computer with a performance of greater than 1.5 exaflops.
Using artificial neural networks designed to emulate the inner workings of the human brain, deep-learning algorithms deftly peruse and analyze large quantities of data. Applying this technique to science problems can help unearth historically elusive solutions.
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.